New York State Teachers Retirement System lessened its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 810,669 shares of the company's stock after selling 40,300 shares during the period. New York State Teachers Retirement System owned approximately 0.10% of Colgate-Palmolive worth $73,698,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Banque Pictet & Cie SA lifted its holdings in shares of Colgate-Palmolive by 4.6% in the 4th quarter. Banque Pictet & Cie SA now owns 181,840 shares of the company's stock worth $16,531,000 after acquiring an additional 8,057 shares during the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of Colgate-Palmolive by 1.7% in the 4th quarter. V Square Quantitative Management LLC now owns 15,598 shares of the company's stock worth $1,418,000 after acquiring an additional 266 shares during the last quarter. Farmers & Merchants Trust Co of Chambersburg PA lifted its holdings in shares of Colgate-Palmolive by 34.7% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 970 shares of the company's stock worth $88,000 after acquiring an additional 250 shares during the last quarter. Asset Management One Co. Ltd. lifted its holdings in shares of Colgate-Palmolive by 4.3% in the 4th quarter. Asset Management One Co. Ltd. now owns 392,938 shares of the company's stock worth $36,076,000 after acquiring an additional 16,036 shares during the last quarter. Finally, Avestar Capital LLC lifted its holdings in shares of Colgate-Palmolive by 14.4% in the 4th quarter. Avestar Capital LLC now owns 5,142 shares of the company's stock worth $467,000 after acquiring an additional 649 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.
Analyst Ratings Changes
A number of research firms recently commented on CL. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. Barclays lowered their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Finally, UBS Group reduced their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of "Hold" and an average target price of $101.16.
Read Our Latest Stock Report on Colgate-Palmolive
Colgate-Palmolive Stock Up 0.4 %
CL stock traded up $0.37 during trading on Tuesday, hitting $86.41. 3,827,625 shares of the stock traded hands, compared to its average volume of 4,960,612. Colgate-Palmolive has a 1 year low of $83.70 and a 1 year high of $109.30. The firm's 50 day moving average is $89.39 and its two-hundred day moving average is $96.22. The stock has a market cap of $70.60 billion, a price-to-earnings ratio of 24.55, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business posted $0.87 EPS. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.73 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is 56.82%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.